Zofran, or ondansetron hydrochloride, is an oral rapidly disintegrating tablet produced by GlaxoSmithKline to treat nausea and vomiting in cancer patients undergoing chemotherapy, radiation therapy, or surgery. The FDA approved the drug for that purpose in 1991.
However, Zofran has been prescribed heavily for off-label use to treat extreme morning sickness in pregnant women.
Birth Defects Associated with Zofran
Some studies have shown that Zofran can cause craniofacial deformities in children born to mothers who took Zofran during their first trimester. The studies show the child is twice as likely to form a cleft palate.
The FDA has also warned that Zofran can cause serious heart problems in those taking it. Zofran may be the cause of congenital heart defects in children whose mothers took the drug while pregnant to treat morning sickness.
How do I know if I have a case?
McDivitt Law Firm is currently assisting clients who were prescribed and took Zofran during pregnancy and had a child born with:
- Cleft lip/palate or other craniofacial deformity, and/or
- A congenital heart defect.
Other birth defects may be associated with Zofran. If you or someone you know is concerned that the use of Zofran during pregnancy could be the cause of any complications, call McDivitt Law Firm today for a free consultation at 877-846-4878, or fill out a free case evaluation form.